MEDIROM Healthcare Technologies Inc. announced that its subsidiary, MEDIROM MOTHER Labs Inc., has approved a private placement of new shares to two officers as part of its Series A financing round, valuing the subsidiary at JPY9 billion.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-098069), on October 09, 2025, and is solely responsible for the information contained therein.
Comments